4.8 Article

Hyaluronic Acid-Guided Cerasome Nano-Agents for Simultaneous Imaging and Treatment of Advanced Atherosclerosis

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Reconstituted HDL as a therapeutic delivery device

Colin A. Fox et al.

Summary: Research on pre beta HDL and rHDL has advanced our understanding of Reverse Cholesterol Transport pathway. rHDL can be easily generated in vitro, leading to novel applications such as promoting regression of atherosclerosis and delivering hydrophobic bioactive molecules. This technology is still in its early stages, with the full potential of these nanoparticles yet to be discovered.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2021)

Review Biotechnology & Applied Microbiology

Targeting inflammation in atherosclerosis - from experimental insights to the clinic

Oliver Soehnlein et al.

Summary: Inflammation plays a substantial role in atherosclerosis and targeting inflammatory pathways could provide a promising new avenue to prevent and treat the disease. Clinical studies have shown that modulation of inflammation can help prevent the clinical complications of atherosclerosis. Refining strategies for combatting inflammation in the disease is crucial for further progress in managing atherosclerotic risk.

NATURE REVIEWS DRUG DISCOVERY (2021)

Review Peripheral Vascular Disease

Novel RNAi-Based Therapies for Atherosclerosis

Anna-Kaisa Ruotsalainen et al.

Summary: Recent RNAi-based therapies targeting atherosclerosis risk factors, such as blood cholesterol levels, have shown promise in clinical trials, with inclisiran as one of the most advanced treatments approved for hypercholesterolemia. The effectiveness and niche of these new drugs in the cardiovascular disease market will need further evaluation as more patients are treated with them.

CURRENT ATHEROSCLEROSIS REPORTS (2021)

Review Biochemistry & Molecular Biology

New insights in statins affecting atheromatous plaque macrophages

Carmen Haerdtner et al.

Summary: Recent research indicates that statins do not directly interact with macrophages in atherosclerotic plaques, but instead control their functions and assembly indirectly through changes in circulating lipid levels and endothelial activation. Statin-mediated lipid lowering induces regression of plaques characterized by a decline in macrophage content, which may inspire new therapeutic approaches in cardiovascular medicine.

CURRENT OPINION IN LIPIDOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study

Gregory A. Roth et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Review Oncology

CD44 as a tumor biomarker and therapeutic target

Hanxiao Xu et al.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2020)

Article Pharmacology & Pharmacy

The STatin Adverse Treatment Experience Survey: Experience of patients reporting side effects of statin therapy

Terry A. Jacobson et al.

JOURNAL OF CLINICAL LIPIDOLOGY (2019)

Review Cardiac & Cardiovascular Systems

Epidemiology of cardiovascular disease in China: current features and implications

Dong Zhao et al.

NATURE REVIEWS CARDIOLOGY (2019)

Meeting Abstract Cardiac & Cardiovascular Systems

Characteristics of patients prescribed Evolocumab in Europe. Does clinical use match clinical guidelines?

K. Ray et al.

EUROPEAN HEART JOURNAL (2018)

Article Cardiac & Cardiovascular Systems

Statin Use and Adverse Effects Among Adults > 75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

Michael G. Nanna et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)

Review Cardiac & Cardiovascular Systems

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions

Paolo Raggi et al.

ATHEROSCLEROSIS (2018)

Article Cardiac & Cardiovascular Systems

Statin related adverse effects and patient education: a study from resource limited settings

Rubina Mulchandani et al.

ACTA CARDIOLOGICA (2018)

Review Cardiac & Cardiovascular Systems

Inflammation in atherosclerosis

Soraya Taleb

ARCHIVES OF CARDIOVASCULAR DISEASES (2016)

Article Cardiac & Cardiovascular Systems

Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications

Jeremy D. Kratz et al.

CARDIOVASCULAR DRUGS AND THERAPY (2016)

Review Biotechnology & Applied Microbiology

Nanotechnology in diagnosis and treatment of coronary artery disease

Mahdi Karimi et al.

NANOMEDICINE (2016)

Article Chemistry, Multidisciplinary

Stabilized liposomal nanohybrid cerasomes for drug delivery applications

Zhong Cao et al.

CHEMICAL COMMUNICATIONS (2010)

Article Hematology

CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice

Liang Zhao et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)

Article Medicine, Research & Experimental

The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation

CA Cuff et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)